|
|
|
Insider
Information: |
Shacham Sharon |
Relationship: |
Chief Scientific Officer |
City: |
Natick |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
958,131 |
|
Indirect Shares
|
713,757 |
|
|
Direct
Value |
$928,525 |
|
|
Indirect Value
|
$691,702 |
|
|
Total
Shares |
1,671,888 |
|
|
Total
Value |
$1,620,227 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
12
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
12
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-12.0
|
Percentage
Gain/Loss : |
0.0%
|
-553.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Karyopharm Therapeutics Inc. |
KPTI |
Chief Scientific Officer |
2022-03-29 |
958,131 |
2022-03-29 |
713,757 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
146 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2020-08-17 |
4 |
AS |
$15.00 |
$22,155 |
D/D |
(1,477) |
756,489 |
0 |
% |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2020-05-07 |
4 |
OE |
$4.75 |
$35,640 |
D/D |
7,500 |
763,989 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2020-05-07 |
4 |
OE |
$4.75 |
$35,640 |
I/I |
7,500 |
562,622 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2020-06-09 |
4 |
OE |
$4.75 |
$35,640 |
D/D |
7,500 |
763,989 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2020-06-10 |
4 |
OE |
$4.75 |
$35,640 |
I/I |
7,500 |
562,622 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2018-11-26 |
4 |
OE |
$4.75 |
$45,619 |
I/I |
9,600 |
521,743 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2018-08-20 |
4 |
OE |
$4.75 |
$47,520 |
I/I |
10,000 |
522,143 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2018-09-18 |
4 |
OE |
$4.75 |
$47,520 |
I/I |
10,000 |
522,143 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2018-10-18 |
4 |
OE |
$4.75 |
$47,520 |
I/I |
10,000 |
522,143 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2019-09-16 |
4 |
OE |
$4.75 |
$47,520 |
I/I |
10,000 |
539,767 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2019-09-16 |
4 |
OE |
$4.75 |
$47,520 |
D/D |
10,000 |
741,134 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2019-11-01 |
4 |
OE |
$4.75 |
$47,520 |
I/I |
10,000 |
539,767 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2019-11-01 |
4 |
OE |
$4.75 |
$47,520 |
D/D |
10,000 |
741,134 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2019-11-08 |
4 |
OE |
$4.75 |
$47,520 |
D/D |
10,000 |
741,134 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2019-11-11 |
4 |
OE |
$4.75 |
$47,520 |
I/I |
10,000 |
539,767 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2019-12-09 |
4 |
OE |
$4.75 |
$47,520 |
D/D |
10,000 |
741,134 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2019-12-10 |
4 |
OE |
$4.75 |
$47,520 |
I/I |
10,000 |
539,767 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2020-01-08 |
4 |
OE |
$4.75 |
$47,520 |
D/D |
10,000 |
753,506 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2020-01-09 |
4 |
OE |
$4.75 |
$47,520 |
I/I |
10,000 |
552,139 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2020-02-10 |
4 |
OE |
$4.75 |
$47,520 |
D/D |
10,000 |
753,506 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2020-02-11 |
4 |
OE |
$4.75 |
$47,520 |
I/I |
10,000 |
552,139 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2020-03-09 |
4 |
OE |
$4.75 |
$47,520 |
D/D |
10,000 |
766,489 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2020-03-10 |
4 |
OE |
$4.75 |
$47,520 |
I/I |
10,000 |
565,122 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2020-04-08 |
4 |
OE |
$4.75 |
$47,520 |
D/D |
10,000 |
766,489 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
President & CSO |
|
2020-04-09 |
4 |
OE |
$4.75 |
$47,520 |
I/I |
10,000 |
565,122 |
0 |
- |
|
146 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|